"Myocytes, Cardiac" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).
| Descriptor ID |
D032383
|
| MeSH Number(s) |
A07.541.704.570 A10.690.552.750.570 A11.620.500
|
| Concept/Terms |
Myocytes, Cardiac- Myocytes, Cardiac
- Cardiac Myocyte
- Cardiac Myocytes
- Myocyte, Cardiac
- Muscle Cells, Heart
- Cell, Heart Muscle
- Cells, Heart Muscle
- Heart Muscle Cell
- Heart Muscle Cells
- Muscle Cell, Heart
- Cardiomyocytes
- Cardiomyocyte
- Muscle Cells, Cardiac
- Cardiac Muscle Cell
- Cardiac Muscle Cells
- Cell, Cardiac Muscle
- Cells, Cardiac Muscle
- Muscle Cell, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Myocytes, Cardiac".
Below are MeSH descriptors whose meaning is more specific than "Myocytes, Cardiac".
This graph shows the total number of publications written about "Myocytes, Cardiac" by people in this website by year, and whether "Myocytes, Cardiac" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 4 | 3 | 7 |
| 2004 | 7 | 7 | 14 |
| 2005 | 2 | 5 | 7 |
| 2006 | 4 | 5 | 9 |
| 2007 | 9 | 7 | 16 |
| 2008 | 15 | 8 | 23 |
| 2009 | 6 | 5 | 11 |
| 2010 | 7 | 9 | 16 |
| 2011 | 10 | 8 | 18 |
| 2012 | 5 | 7 | 12 |
| 2013 | 10 | 7 | 17 |
| 2014 | 19 | 2 | 21 |
| 2015 | 14 | 7 | 21 |
| 2016 | 16 | 11 | 27 |
| 2017 | 18 | 6 | 24 |
| 2018 | 16 | 9 | 25 |
| 2019 | 13 | 8 | 21 |
| 2020 | 15 | 6 | 21 |
| 2021 | 14 | 10 | 24 |
| 2022 | 3 | 11 | 14 |
| 2023 | 5 | 11 | 16 |
| 2024 | 11 | 7 | 18 |
| 2025 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myocytes, Cardiac" by people in Profiles.
-
Cardiovascular dysfunction and altered lysosomal signaling in a murine model of acid sphingomyelinase deficiency. J Mol Med (Berl). 2025 May; 103(5):599-617.
-
Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis. Eur Heart J. 2025 Apr 01; 46(13):1250-1262.
-
XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity. Circulation. 2025 Jun 03; 151(22):1583-1605.
-
Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk. Nat Genet. 2025 Mar; 57(3):548-562.
-
Macrophage-mediated IL-6 signaling drives ryanodine receptor-2 calcium leak in postoperative atrial fibrillation. J Clin Invest. 2025 May 01; 135(9).
-
Bioprinted optoelectronically active cardiac tissues. Sci Adv. 2025 Jan 24; 11(4):eadt7210.
-
Fibroblast-specific TGF-? signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovasc Res. 2024 Dec 14; 120(16):2047-2063.
-
Ultrathin rubbery bio-optoelectronic stimulators for untethered cardiac stimulation. Sci Adv. 2024 Dec 06; 10(49):eadq5061.
-
PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. Diabetes. 2024 Nov 01; 73(11):1805-1820.
-
STEMIN and YAP5SA, the future of heart repair? Exp Biol Med (Maywood). 2024; 249:10246.